BGI Americas, AiLife Partner on Clinical WGS Diagnostics for Genetic Disorders

BGI Americas, the U.S. subsidiary of BGI Genomics, will partner with AiLife Diagnostics to jointly develop and market a clinical whole genome sequencing (WGS)...
Source: Christoph Bock/Max Planck Institute for Informatics

Cancer Prognosis and Survival Predictions Aided by DNA Methylation Patterns

DNA methylation could improve outcomes via more accurate diagnoses of indolent or aggressive tumors requiring different treatment regimens
Source: grapestock/Getty Images

Interpace Names Best Med Exclusive Provider of Its Tests for Israel

With interest growing for its tests, Interpace establishes processes for logistics, specimen handling to allow working with global partners.

Eurofins BPT Munich to Market SenzaGen GARD Skin Allergy Tests

Eurofins plans to immediately include GARDskin and the add-on test GARDpotency to cosmetic, chemical, and pharmaceutical clients worldwide.
Source: Getty Images

Genome Medical to Incorporate Fabric Genomics’ Clinical Interpretation

The collaboration will provide Genome Medical's doctors and genetic counselors with augmented genomic data analysis and interpretation.

Illumina Expands East, Opening ‘Solutions Center’ in Baltimore

Illumina said today it has opened its first commercial location on the East Coast, within the University of Maryland (UM) BioPark in Baltimore. The Illumina...
Source: HIPhotos/Getty Images

Genetic Diseases More Severe with Adverse Coding, Regulatory Variant Combos

New York Genome Center, Columbia investigators unravel why some carriers of disease genes are spared while others suffer worse effects
Source: Getty Images

Regeneron Enters Sequencing Collaboration with GSK, UK Biobank

Regeneron and GSK commit to initial sequencing of 50,000 samples focused on the exome, the protein encoding regions of the genome.

Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina

From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.

TGen, ABL to Launch Compact NGS-Based TB Diagnostic

Advanced Biological Laboratories (ABL) plans to launch a portable and affordable test for tuberculosis (TB) designed by the Translational Genomics Research Institute (TGen), an...
Scroll Up